nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—MPO—Alzheimer's disease	0.216	0.343	CbGaD
Mesalazine—PPARG—Alzheimer's disease	0.192	0.304	CbGaD
Mesalazine—PTGS1—Alzheimer's disease	0.142	0.225	CbGaD
Mesalazine—PTGS2—Alzheimer's disease	0.0811	0.128	CbGaD
Mesalazine—MPO—blood vessel—Alzheimer's disease	0.00253	0.0759	CbGeAlD
Mesalazine—PPARG—blood vessel—Alzheimer's disease	0.00225	0.0673	CbGeAlD
Mesalazine—IKBKB—embryo—Alzheimer's disease	0.00215	0.0646	CbGeAlD
Mesalazine—IKBKB—telencephalon—Alzheimer's disease	0.00175	0.0525	CbGeAlD
Mesalazine—Diflunisal—TTR—Alzheimer's disease	0.00171	0.32	CrCbGaD
Mesalazine—CHUK—cerebellum—Alzheimer's disease	0.00143	0.0429	CbGeAlD
Mesalazine—PPARG—embryo—Alzheimer's disease	0.00134	0.0402	CbGeAlD
Mesalazine—MPO—forebrain—Alzheimer's disease	0.00134	0.04	CbGeAlD
Mesalazine—PTGS1—blood vessel—Alzheimer's disease	0.0012	0.036	CbGeAlD
Mesalazine—PPARG—forebrain—Alzheimer's disease	0.00118	0.0355	CbGeAlD
Mesalazine—CHUK—brain—Alzheimer's disease	0.00116	0.0349	CbGeAlD
Mesalazine—PTGS2—blood vessel—Alzheimer's disease	0.00115	0.0344	CbGeAlD
Mesalazine—IKBKB—nervous system—Alzheimer's disease	0.00103	0.031	CbGeAlD
Mesalazine—IKBKB—central nervous system—Alzheimer's disease	0.000995	0.0298	CbGeAlD
Mesalazine—IKBKB—cerebellum—Alzheimer's disease	0.000973	0.0292	CbGeAlD
Mesalazine—ALOX5—nervous system—Alzheimer's disease	0.000857	0.0257	CbGeAlD
Mesalazine—ALOX5—central nervous system—Alzheimer's disease	0.000825	0.0247	CbGeAlD
Mesalazine—ALOX5—cerebellum—Alzheimer's disease	0.000806	0.0242	CbGeAlD
Mesalazine—IKBKB—brain—Alzheimer's disease	0.00079	0.0237	CbGeAlD
Mesalazine—MPO—nervous system—Alzheimer's disease	0.000725	0.0217	CbGeAlD
Mesalazine—MPO—central nervous system—Alzheimer's disease	0.000698	0.0209	CbGeAlD
Mesalazine—PTGS2—embryo—Alzheimer's disease	0.000685	0.0205	CbGeAlD
Mesalazine—ALOX5—brain—Alzheimer's disease	0.000655	0.0196	CbGeAlD
Mesalazine—PPARG—nervous system—Alzheimer's disease	0.000643	0.0193	CbGeAlD
Mesalazine—PTGS1—forebrain—Alzheimer's disease	0.000633	0.019	CbGeAlD
Mesalazine—PPARG—central nervous system—Alzheimer's disease	0.000619	0.0186	CbGeAlD
Mesalazine—PTGS2—forebrain—Alzheimer's disease	0.000605	0.0182	CbGeAlD
Mesalazine—PTGS1—telencephalon—Alzheimer's disease	0.000582	0.0175	CbGeAlD
Mesalazine—PTGS2—telencephalon—Alzheimer's disease	0.000557	0.0167	CbGeAlD
Mesalazine—MPO—brain—Alzheimer's disease	0.000554	0.0166	CbGeAlD
Mesalazine—PPARG—brain—Alzheimer's disease	0.000492	0.0147	CbGeAlD
Mesalazine—Salicylate-sodium—PTGS1—Alzheimer's disease	0.000428	0.08	CrCbGaD
Mesalazine—Aminosalicylic Acid—MPO—Alzheimer's disease	0.000421	0.0786	CrCbGaD
Mesalazine—Olsalazine—PPARG—Alzheimer's disease	0.000397	0.0742	CrCbGaD
Mesalazine—PTGS1—nervous system—Alzheimer's disease	0.000344	0.0103	CbGeAlD
Mesalazine—PTGS1—central nervous system—Alzheimer's disease	0.000331	0.00993	CbGeAlD
Mesalazine—PTGS2—nervous system—Alzheimer's disease	0.000329	0.00986	CbGeAlD
Mesalazine—PTGS2—central nervous system—Alzheimer's disease	0.000316	0.00949	CbGeAlD
Mesalazine—PTGS2—cerebellum—Alzheimer's disease	0.000309	0.00927	CbGeAlD
Mesalazine—Olsalazine—PTGS1—Alzheimer's disease	0.000293	0.0548	CrCbGaD
Mesalazine—Diflunisal—PTGS1—Alzheimer's disease	0.000276	0.0516	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS1—Alzheimer's disease	0.000276	0.0516	CrCbGaD
Mesalazine—Dopamine—MAOB—Alzheimer's disease	0.000274	0.0511	CrCbGaD
Mesalazine—PTGS1—brain—Alzheimer's disease	0.000263	0.00788	CbGeAlD
Mesalazine—PTGS2—brain—Alzheimer's disease	0.000251	0.00753	CbGeAlD
Mesalazine—Salicylate-sodium—PTGS2—Alzheimer's disease	0.000245	0.0457	CrCbGaD
Mesalazine—Haemoglobin—Memantine—Alzheimer's disease	0.000199	0.00102	CcSEcCtD
Mesalazine—Rhinitis—Memantine—Alzheimer's disease	0.000199	0.00101	CcSEcCtD
Mesalazine—Hepatitis—Memantine—Alzheimer's disease	0.000198	0.00101	CcSEcCtD
Mesalazine—Haemorrhage—Memantine—Alzheimer's disease	0.000198	0.00101	CcSEcCtD
Mesalazine—Shock—Galantamine—Alzheimer's disease	0.000197	0.001	CcSEcCtD
Mesalazine—Pharyngitis—Memantine—Alzheimer's disease	0.000197	0.001	CcSEcCtD
Mesalazine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000196	0.001	CcSEcCtD
Mesalazine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000196	0.000999	CcSEcCtD
Mesalazine—Chills—Donepezil—Alzheimer's disease	0.000196	0.000998	CcSEcCtD
Mesalazine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000196	0.000998	CcSEcCtD
Mesalazine—Tachycardia—Galantamine—Alzheimer's disease	0.000195	0.000995	CcSEcCtD
Mesalazine—Oedema peripheral—Memantine—Alzheimer's disease	0.000195	0.000995	CcSEcCtD
Mesalazine—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000195	0.000993	CcSEcCtD
Mesalazine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000195	0.000993	CcSEcCtD
Mesalazine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000195	0.000991	CcSEcCtD
Mesalazine—Skin disorder—Galantamine—Alzheimer's disease	0.000195	0.000991	CcSEcCtD
Mesalazine—Urethral disorder—Memantine—Alzheimer's disease	0.000194	0.00099	CcSEcCtD
Mesalazine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000194	0.000988	CcSEcCtD
Mesalazine—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000194	0.000988	CcSEcCtD
Mesalazine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000194	0.000986	CcSEcCtD
Mesalazine—Alopecia—Donepezil—Alzheimer's disease	0.000193	0.000983	CcSEcCtD
Mesalazine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000193	0.000981	CcSEcCtD
Mesalazine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000192	0.000976	CcSEcCtD
Mesalazine—Mental disorder—Donepezil—Alzheimer's disease	0.000191	0.000975	CcSEcCtD
Mesalazine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000191	0.000974	CcSEcCtD
Mesalazine—Anorexia—Galantamine—Alzheimer's disease	0.000191	0.000972	CcSEcCtD
Mesalazine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000191	0.000971	CcSEcCtD
Mesalazine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00019	0.000969	CcSEcCtD
Mesalazine—Erythema—Donepezil—Alzheimer's disease	0.00019	0.000969	CcSEcCtD
Mesalazine—Erythema multiforme—Memantine—Alzheimer's disease	0.000188	0.000955	CcSEcCtD
Mesalazine—Flatulence—Donepezil—Alzheimer's disease	0.000187	0.000954	CcSEcCtD
Mesalazine—Hypotension—Galantamine—Alzheimer's disease	0.000187	0.000953	CcSEcCtD
Mesalazine—Tension—Donepezil—Alzheimer's disease	0.000187	0.00095	CcSEcCtD
Mesalazine—Dysgeusia—Donepezil—Alzheimer's disease	0.000186	0.000948	CcSEcCtD
Mesalazine—Eye disorder—Memantine—Alzheimer's disease	0.000185	0.000944	CcSEcCtD
Mesalazine—Tinnitus—Memantine—Alzheimer's disease	0.000185	0.000942	CcSEcCtD
Mesalazine—Nervousness—Donepezil—Alzheimer's disease	0.000185	0.000941	CcSEcCtD
Mesalazine—Cardiac disorder—Memantine—Alzheimer's disease	0.000184	0.000938	CcSEcCtD
Mesalazine—Back pain—Donepezil—Alzheimer's disease	0.000184	0.000937	CcSEcCtD
Mesalazine—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000183	0.000934	CcSEcCtD
Mesalazine—Muscle spasms—Donepezil—Alzheimer's disease	0.000183	0.000931	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000182	0.000929	CcSEcCtD
Mesalazine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000181	0.000924	CcSEcCtD
Mesalazine—Insomnia—Galantamine—Alzheimer's disease	0.000181	0.000923	CcSEcCtD
Mesalazine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000181	0.000921	CcSEcCtD
Mesalazine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00018	0.000917	CcSEcCtD
Mesalazine—Angiopathy—Memantine—Alzheimer's disease	0.00018	0.000917	CcSEcCtD
Mesalazine—Paraesthesia—Galantamine—Alzheimer's disease	0.00018	0.000916	CcSEcCtD
Mesalazine—Vision blurred—Donepezil—Alzheimer's disease	0.000179	0.000913	CcSEcCtD
Mesalazine—Immune system disorder—Memantine—Alzheimer's disease	0.000179	0.000912	CcSEcCtD
Mesalazine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000179	0.00091	CcSEcCtD
Mesalazine—Tremor—Donepezil—Alzheimer's disease	0.000178	0.000907	CcSEcCtD
Mesalazine—Somnolence—Galantamine—Alzheimer's disease	0.000178	0.000907	CcSEcCtD
Mesalazine—Chills—Memantine—Alzheimer's disease	0.000178	0.000906	CcSEcCtD
Mesalazine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000176	0.000899	CcSEcCtD
Mesalazine—Dyspepsia—Galantamine—Alzheimer's disease	0.000176	0.000898	CcSEcCtD
Mesalazine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000176	0.000897	CcSEcCtD
Mesalazine—Anaemia—Donepezil—Alzheimer's disease	0.000176	0.000895	CcSEcCtD
Mesalazine—Alopecia—Memantine—Alzheimer's disease	0.000175	0.000893	CcSEcCtD
Mesalazine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000175	0.000891	CcSEcCtD
Mesalazine—Chills—Rivastigmine—Alzheimer's disease	0.000174	0.000887	CcSEcCtD
Mesalazine—Decreased appetite—Galantamine—Alzheimer's disease	0.000174	0.000887	CcSEcCtD
Mesalazine—Mental disorder—Memantine—Alzheimer's disease	0.000174	0.000885	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000173	0.000881	CcSEcCtD
Mesalazine—Fatigue—Galantamine—Alzheimer's disease	0.000173	0.000879	CcSEcCtD
Mesalazine—Malaise—Donepezil—Alzheimer's disease	0.000171	0.000873	CcSEcCtD
Mesalazine—Alopecia—Rivastigmine—Alzheimer's disease	0.000171	0.000873	CcSEcCtD
Mesalazine—Constipation—Galantamine—Alzheimer's disease	0.000171	0.000872	CcSEcCtD
Mesalazine—Vertigo—Donepezil—Alzheimer's disease	0.000171	0.00087	CcSEcCtD
Mesalazine—Syncope—Donepezil—Alzheimer's disease	0.000171	0.000869	CcSEcCtD
Mesalazine—Flatulence—Memantine—Alzheimer's disease	0.00017	0.000867	CcSEcCtD
Mesalazine—Mental disorder—Rivastigmine—Alzheimer's disease	0.00017	0.000866	CcSEcCtD
Mesalazine—Tension—Memantine—Alzheimer's disease	0.000169	0.000863	CcSEcCtD
Mesalazine—Dysgeusia—Memantine—Alzheimer's disease	0.000169	0.000861	CcSEcCtD
Mesalazine—Erythema—Rivastigmine—Alzheimer's disease	0.000169	0.00086	CcSEcCtD
Mesalazine—Nervousness—Memantine—Alzheimer's disease	0.000168	0.000854	CcSEcCtD
Mesalazine—Olsalazine—PTGS2—Alzheimer's disease	0.000168	0.0313	CrCbGaD
Mesalazine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000167	0.000851	CcSEcCtD
Mesalazine—Back pain—Memantine—Alzheimer's disease	0.000167	0.000851	CcSEcCtD
Mesalazine—Flatulence—Rivastigmine—Alzheimer's disease	0.000166	0.000848	CcSEcCtD
Mesalazine—Cough—Donepezil—Alzheimer's disease	0.000166	0.000845	CcSEcCtD
Mesalazine—Tension—Rivastigmine—Alzheimer's disease	0.000166	0.000844	CcSEcCtD
Mesalazine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000165	0.000842	CcSEcCtD
Mesalazine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000165	0.000841	CcSEcCtD
Mesalazine—Hypertension—Donepezil—Alzheimer's disease	0.000164	0.000836	CcSEcCtD
Mesalazine—Nervousness—Rivastigmine—Alzheimer's disease	0.000164	0.000836	CcSEcCtD
Mesalazine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000164	0.000834	CcSEcCtD
Mesalazine—Back pain—Rivastigmine—Alzheimer's disease	0.000163	0.000832	CcSEcCtD
Mesalazine—Vision blurred—Memantine—Alzheimer's disease	0.000163	0.000829	CcSEcCtD
Mesalazine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000162	0.000827	CcSEcCtD
Mesalazine—Chest pain—Donepezil—Alzheimer's disease	0.000162	0.000825	CcSEcCtD
Mesalazine—Arthralgia—Donepezil—Alzheimer's disease	0.000162	0.000825	CcSEcCtD
Mesalazine—Myalgia—Donepezil—Alzheimer's disease	0.000162	0.000825	CcSEcCtD
Mesalazine—Tremor—Memantine—Alzheimer's disease	0.000162	0.000824	CcSEcCtD
Mesalazine—Anxiety—Donepezil—Alzheimer's disease	0.000161	0.000822	CcSEcCtD
Mesalazine—Ill-defined disorder—Memantine—Alzheimer's disease	0.00016	0.000816	CcSEcCtD
Mesalazine—Discomfort—Donepezil—Alzheimer's disease	0.00016	0.000815	CcSEcCtD
Mesalazine—Anaemia—Memantine—Alzheimer's disease	0.00016	0.000813	CcSEcCtD
Mesalazine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000159	0.000811	CcSEcCtD
Mesalazine—Dry mouth—Donepezil—Alzheimer's disease	0.000158	0.000806	CcSEcCtD
Mesalazine—Abdominal pain—Galantamine—Alzheimer's disease	0.000158	0.000806	CcSEcCtD
Mesalazine—Body temperature increased—Galantamine—Alzheimer's disease	0.000158	0.000806	CcSEcCtD
Mesalazine—Tremor—Rivastigmine—Alzheimer's disease	0.000158	0.000806	CcSEcCtD
Mesalazine—Diflunisal—PTGS2—Alzheimer's disease	0.000158	0.0295	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS2—Alzheimer's disease	0.000158	0.0295	CrCbGaD
Mesalazine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000157	0.000798	CcSEcCtD
Mesalazine—Confusional state—Donepezil—Alzheimer's disease	0.000156	0.000797	CcSEcCtD
Mesalazine—Anaemia—Rivastigmine—Alzheimer's disease	0.000156	0.000795	CcSEcCtD
Mesalazine—Malaise—Memantine—Alzheimer's disease	0.000156	0.000793	CcSEcCtD
Mesalazine—Oedema—Donepezil—Alzheimer's disease	0.000155	0.00079	CcSEcCtD
Mesalazine—Vertigo—Memantine—Alzheimer's disease	0.000155	0.00079	CcSEcCtD
Mesalazine—Syncope—Memantine—Alzheimer's disease	0.000155	0.000789	CcSEcCtD
Mesalazine—Leukopenia—Memantine—Alzheimer's disease	0.000155	0.000787	CcSEcCtD
Mesalazine—Infection—Donepezil—Alzheimer's disease	0.000154	0.000785	CcSEcCtD
Mesalazine—Salicylic acid—PTGS1—Alzheimer's disease	0.000153	0.0287	CrCbGaD
Mesalazine—Shock—Donepezil—Alzheimer's disease	0.000153	0.000778	CcSEcCtD
Mesalazine—Palpitations—Memantine—Alzheimer's disease	0.000153	0.000777	CcSEcCtD
Mesalazine—Malaise—Rivastigmine—Alzheimer's disease	0.000152	0.000776	CcSEcCtD
Mesalazine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000152	0.000775	CcSEcCtD
Mesalazine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000152	0.000774	CcSEcCtD
Mesalazine—Vertigo—Rivastigmine—Alzheimer's disease	0.000152	0.000773	CcSEcCtD
Mesalazine—Loss of consciousness—Memantine—Alzheimer's disease	0.000152	0.000773	CcSEcCtD
Mesalazine—Syncope—Rivastigmine—Alzheimer's disease	0.000151	0.000772	CcSEcCtD
Mesalazine—Cough—Memantine—Alzheimer's disease	0.000151	0.000767	CcSEcCtD
Mesalazine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00015	0.000764	CcSEcCtD
Mesalazine—Palpitations—Rivastigmine—Alzheimer's disease	0.000149	0.00076	CcSEcCtD
Mesalazine—Hypertension—Memantine—Alzheimer's disease	0.000149	0.000759	CcSEcCtD
Mesalazine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000148	0.000756	CcSEcCtD
Mesalazine—Anorexia—Donepezil—Alzheimer's disease	0.000148	0.000753	CcSEcCtD
Mesalazine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000148	0.000751	CcSEcCtD
Mesalazine—Cough—Rivastigmine—Alzheimer's disease	0.000147	0.000751	CcSEcCtD
Mesalazine—Chest pain—Memantine—Alzheimer's disease	0.000147	0.000749	CcSEcCtD
Mesalazine—Arthralgia—Memantine—Alzheimer's disease	0.000147	0.000749	CcSEcCtD
Mesalazine—Myalgia—Memantine—Alzheimer's disease	0.000147	0.000749	CcSEcCtD
Mesalazine—Anxiety—Memantine—Alzheimer's disease	0.000146	0.000746	CcSEcCtD
Mesalazine—Hypertension—Rivastigmine—Alzheimer's disease	0.000146	0.000743	CcSEcCtD
Mesalazine—Discomfort—Memantine—Alzheimer's disease	0.000145	0.00074	CcSEcCtD
Mesalazine—Hypotension—Donepezil—Alzheimer's disease	0.000145	0.000739	CcSEcCtD
Mesalazine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000144	0.000732	CcSEcCtD
Mesalazine—Chest pain—Rivastigmine—Alzheimer's disease	0.000144	0.000732	CcSEcCtD
Mesalazine—Myalgia—Rivastigmine—Alzheimer's disease	0.000144	0.000732	CcSEcCtD
Mesalazine—Dry mouth—Memantine—Alzheimer's disease	0.000144	0.000732	CcSEcCtD
Mesalazine—Asthenia—Galantamine—Alzheimer's disease	0.000144	0.000732	CcSEcCtD
Mesalazine—Anxiety—Rivastigmine—Alzheimer's disease	0.000143	0.00073	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000143	0.000727	CcSEcCtD
Mesalazine—Confusional state—Memantine—Alzheimer's disease	0.000142	0.000724	CcSEcCtD
Mesalazine—Discomfort—Rivastigmine—Alzheimer's disease	0.000142	0.000724	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000141	0.00072	CcSEcCtD
Mesalazine—Oedema—Memantine—Alzheimer's disease	0.000141	0.000718	CcSEcCtD
Mesalazine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000141	0.000716	CcSEcCtD
Mesalazine—Insomnia—Donepezil—Alzheimer's disease	0.00014	0.000715	CcSEcCtD
Mesalazine—Infection—Memantine—Alzheimer's disease	0.00014	0.000713	CcSEcCtD
Mesalazine—Paraesthesia—Donepezil—Alzheimer's disease	0.000139	0.00071	CcSEcCtD
Mesalazine—Confusional state—Rivastigmine—Alzheimer's disease	0.000139	0.000708	CcSEcCtD
Mesalazine—Shock—Memantine—Alzheimer's disease	0.000139	0.000706	CcSEcCtD
Mesalazine—Dyspnoea—Donepezil—Alzheimer's disease	0.000138	0.000705	CcSEcCtD
Mesalazine—Nervous system disorder—Memantine—Alzheimer's disease	0.000138	0.000704	CcSEcCtD
Mesalazine—Somnolence—Donepezil—Alzheimer's disease	0.000138	0.000703	CcSEcCtD
Mesalazine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000138	0.000703	CcSEcCtD
Mesalazine—Oedema—Rivastigmine—Alzheimer's disease	0.000138	0.000702	CcSEcCtD
Mesalazine—Tachycardia—Memantine—Alzheimer's disease	0.000138	0.0007	CcSEcCtD
Mesalazine—Diarrhoea—Galantamine—Alzheimer's disease	0.000137	0.000698	CcSEcCtD
Mesalazine—Infection—Rivastigmine—Alzheimer's disease	0.000137	0.000698	CcSEcCtD
Mesalazine—Skin disorder—Memantine—Alzheimer's disease	0.000137	0.000697	CcSEcCtD
Mesalazine—Dyspepsia—Donepezil—Alzheimer's disease	0.000137	0.000696	CcSEcCtD
Mesalazine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000136	0.000694	CcSEcCtD
Mesalazine—Shock—Rivastigmine—Alzheimer's disease	0.000136	0.000691	CcSEcCtD
Mesalazine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000135	0.000689	CcSEcCtD
Mesalazine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000135	0.000687	CcSEcCtD
Mesalazine—Decreased appetite—Donepezil—Alzheimer's disease	0.000135	0.000687	CcSEcCtD
Mesalazine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000135	0.000685	CcSEcCtD
Mesalazine—Anorexia—Memantine—Alzheimer's disease	0.000134	0.000684	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000134	0.000682	CcSEcCtD
Mesalazine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000134	0.000682	CcSEcCtD
Mesalazine—Fatigue—Donepezil—Alzheimer's disease	0.000134	0.000682	CcSEcCtD
Mesalazine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000133	0.000679	CcSEcCtD
Mesalazine—Pain—Donepezil—Alzheimer's disease	0.000133	0.000676	CcSEcCtD
Mesalazine—Constipation—Donepezil—Alzheimer's disease	0.000133	0.000676	CcSEcCtD
Mesalazine—Dizziness—Galantamine—Alzheimer's disease	0.000132	0.000674	CcSEcCtD
Mesalazine—Hypotension—Memantine—Alzheimer's disease	0.000132	0.000671	CcSEcCtD
Mesalazine—Anorexia—Rivastigmine—Alzheimer's disease	0.000131	0.000669	CcSEcCtD
Mesalazine—Hypotension—Rivastigmine—Alzheimer's disease	0.000129	0.000656	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000128	0.000654	CcSEcCtD
Mesalazine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000128	0.000651	CcSEcCtD
Mesalazine—Insomnia—Memantine—Alzheimer's disease	0.000127	0.000649	CcSEcCtD
Mesalazine—Vomiting—Galantamine—Alzheimer's disease	0.000127	0.000649	CcSEcCtD
Mesalazine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000127	0.000646	CcSEcCtD
Mesalazine—Paraesthesia—Memantine—Alzheimer's disease	0.000127	0.000644	CcSEcCtD
Mesalazine—Rash—Galantamine—Alzheimer's disease	0.000126	0.000643	CcSEcCtD
Mesalazine—Dermatitis—Galantamine—Alzheimer's disease	0.000126	0.000643	CcSEcCtD
Mesalazine—Dyspnoea—Memantine—Alzheimer's disease	0.000126	0.00064	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000126	0.00064	CcSEcCtD
Mesalazine—Headache—Galantamine—Alzheimer's disease	0.000125	0.000639	CcSEcCtD
Mesalazine—Somnolence—Memantine—Alzheimer's disease	0.000125	0.000638	CcSEcCtD
Mesalazine—Insomnia—Rivastigmine—Alzheimer's disease	0.000125	0.000635	CcSEcCtD
Mesalazine—Dyspepsia—Memantine—Alzheimer's disease	0.000124	0.000632	CcSEcCtD
Mesalazine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000124	0.00063	CcSEcCtD
Mesalazine—Dopamine—SLC6A4—Alzheimer's disease	0.000124	0.0231	CrCbGaD
Mesalazine—Urticaria—Donepezil—Alzheimer's disease	0.000123	0.000628	CcSEcCtD
Mesalazine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000123	0.000626	CcSEcCtD
Mesalazine—Abdominal pain—Donepezil—Alzheimer's disease	0.000123	0.000625	CcSEcCtD
Mesalazine—Body temperature increased—Donepezil—Alzheimer's disease	0.000123	0.000625	CcSEcCtD
Mesalazine—Somnolence—Rivastigmine—Alzheimer's disease	0.000123	0.000624	CcSEcCtD
Mesalazine—Decreased appetite—Memantine—Alzheimer's disease	0.000123	0.000624	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000122	0.00062	CcSEcCtD
Mesalazine—Fatigue—Memantine—Alzheimer's disease	0.000121	0.000619	CcSEcCtD
Mesalazine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000121	0.000618	CcSEcCtD
Mesalazine—Pain—Memantine—Alzheimer's disease	0.000121	0.000614	CcSEcCtD
Mesalazine—Constipation—Memantine—Alzheimer's disease	0.000121	0.000614	CcSEcCtD
Mesalazine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00012	0.00061	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000119	0.000606	CcSEcCtD
Mesalazine—Nausea—Galantamine—Alzheimer's disease	0.000119	0.000606	CcSEcCtD
Mesalazine—Fatigue—Rivastigmine—Alzheimer's disease	0.000119	0.000605	CcSEcCtD
Mesalazine—Constipation—Rivastigmine—Alzheimer's disease	0.000118	0.0006	CcSEcCtD
Mesalazine—Pain—Rivastigmine—Alzheimer's disease	0.000118	0.0006	CcSEcCtD
Mesalazine—Feeling abnormal—Memantine—Alzheimer's disease	0.000116	0.000591	CcSEcCtD
Mesalazine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000115	0.000587	CcSEcCtD
Mesalazine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000114	0.000582	CcSEcCtD
Mesalazine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000114	0.000579	CcSEcCtD
Mesalazine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000113	0.000574	CcSEcCtD
Mesalazine—Urticaria—Memantine—Alzheimer's disease	0.000112	0.00057	CcSEcCtD
Mesalazine—Body temperature increased—Memantine—Alzheimer's disease	0.000111	0.000567	CcSEcCtD
Mesalazine—Abdominal pain—Memantine—Alzheimer's disease	0.000111	0.000567	CcSEcCtD
Mesalazine—Asthenia—Donepezil—Alzheimer's disease	0.000111	0.000567	CcSEcCtD
Mesalazine—Pruritus—Donepezil—Alzheimer's disease	0.00011	0.000559	CcSEcCtD
Mesalazine—Urticaria—Rivastigmine—Alzheimer's disease	0.00011	0.000558	CcSEcCtD
Mesalazine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000109	0.000555	CcSEcCtD
Mesalazine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000109	0.000555	CcSEcCtD
Mesalazine—Diarrhoea—Donepezil—Alzheimer's disease	0.000106	0.000541	CcSEcCtD
Mesalazine—Hypersensitivity—Memantine—Alzheimer's disease	0.000104	0.000529	CcSEcCtD
Mesalazine—Dizziness—Donepezil—Alzheimer's disease	0.000103	0.000523	CcSEcCtD
Mesalazine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000102	0.000517	CcSEcCtD
Mesalazine—Asthenia—Memantine—Alzheimer's disease	0.000101	0.000515	CcSEcCtD
Mesalazine—Pruritus—Memantine—Alzheimer's disease	9.97e-05	0.000508	CcSEcCtD
Mesalazine—Asthenia—Rivastigmine—Alzheimer's disease	9.89e-05	0.000504	CcSEcCtD
Mesalazine—Vomiting—Donepezil—Alzheimer's disease	9.87e-05	0.000503	CcSEcCtD
Mesalazine—Rash—Donepezil—Alzheimer's disease	9.79e-05	0.000498	CcSEcCtD
Mesalazine—Dermatitis—Donepezil—Alzheimer's disease	9.78e-05	0.000498	CcSEcCtD
Mesalazine—Pruritus—Rivastigmine—Alzheimer's disease	9.75e-05	0.000497	CcSEcCtD
Mesalazine—Headache—Donepezil—Alzheimer's disease	9.72e-05	0.000495	CcSEcCtD
Mesalazine—Diarrhoea—Memantine—Alzheimer's disease	9.64e-05	0.000491	CcSEcCtD
Mesalazine—Diarrhoea—Rivastigmine—Alzheimer's disease	9.43e-05	0.00048	CcSEcCtD
Mesalazine—L-DOPA—CYP2D6—Alzheimer's disease	9.35e-05	0.0175	CrCbGaD
Mesalazine—Dizziness—Memantine—Alzheimer's disease	9.32e-05	0.000475	CcSEcCtD
Mesalazine—Nausea—Donepezil—Alzheimer's disease	9.22e-05	0.00047	CcSEcCtD
Mesalazine—Dizziness—Rivastigmine—Alzheimer's disease	9.12e-05	0.000464	CcSEcCtD
Mesalazine—Vomiting—Memantine—Alzheimer's disease	8.96e-05	0.000456	CcSEcCtD
Mesalazine—Rash—Memantine—Alzheimer's disease	8.89e-05	0.000453	CcSEcCtD
Mesalazine—Dermatitis—Memantine—Alzheimer's disease	8.88e-05	0.000452	CcSEcCtD
Mesalazine—Headache—Memantine—Alzheimer's disease	8.83e-05	0.00045	CcSEcCtD
Mesalazine—Salicylic acid—PTGS2—Alzheimer's disease	8.77e-05	0.0164	CrCbGaD
Mesalazine—Vomiting—Rivastigmine—Alzheimer's disease	8.77e-05	0.000446	CcSEcCtD
Mesalazine—Rash—Rivastigmine—Alzheimer's disease	8.69e-05	0.000443	CcSEcCtD
Mesalazine—Dopamine—CYP2D6—Alzheimer's disease	8.69e-05	0.0162	CrCbGaD
Mesalazine—Dermatitis—Rivastigmine—Alzheimer's disease	8.68e-05	0.000442	CcSEcCtD
Mesalazine—Headache—Rivastigmine—Alzheimer's disease	8.64e-05	0.00044	CcSEcCtD
Mesalazine—Nausea—Memantine—Alzheimer's disease	8.37e-05	0.000426	CcSEcCtD
Mesalazine—Nausea—Rivastigmine—Alzheimer's disease	8.19e-05	0.000417	CcSEcCtD
Mesalazine—PTGS2—Disease—EIF2AK2—Alzheimer's disease	1.37e-05	0.000103	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NPY—Alzheimer's disease	1.37e-05	0.000103	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IAPP—Alzheimer's disease	1.36e-05	0.000102	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ABCA1—Alzheimer's disease	1.36e-05	0.000102	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PSEN2—Alzheimer's disease	1.35e-05	0.000101	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GAPDH—Alzheimer's disease	1.35e-05	0.000101	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—BCL2—Alzheimer's disease	1.34e-05	0.000101	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.33e-05	9.99e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—S100B—Alzheimer's disease	1.33e-05	9.98e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1A—Alzheimer's disease	1.33e-05	9.96e-05	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.32e-05	9.94e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CRH—Alzheimer's disease	1.32e-05	9.93e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—MEF2C—Alzheimer's disease	1.28e-05	9.63e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—AGER—Alzheimer's disease	1.27e-05	9.55e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PSEN2—Alzheimer's disease	1.26e-05	9.46e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PRKCG—Alzheimer's disease	1.26e-05	9.45e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PPARG—Alzheimer's disease	1.26e-05	9.44e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NPS—Alzheimer's disease	1.26e-05	9.42e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PPP3CA—Alzheimer's disease	1.25e-05	9.37e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NPY—Alzheimer's disease	1.24e-05	9.34e-05	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—Alzheimer's disease	1.24e-05	9.31e-05	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.24e-05	9.28e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IAPP—Alzheimer's disease	1.24e-05	9.28e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—INS—Alzheimer's disease	1.23e-05	9.26e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CST3—Alzheimer's disease	1.23e-05	9.25e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PTK2B—Alzheimer's disease	1.23e-05	9.24e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.23e-05	9.19e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CHAT—Alzheimer's disease	1.22e-05	9.18e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—TPI1—Alzheimer's disease	1.22e-05	9.18e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—Alzheimer's disease	1.22e-05	9.15e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—BCL2—Alzheimer's disease	1.22e-05	9.15e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—VEGFA—Alzheimer's disease	1.21e-05	9.1e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1A—Alzheimer's disease	1.2e-05	9.03e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CRH—Alzheimer's disease	1.2e-05	9.01e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SST—Alzheimer's disease	1.2e-05	8.98e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GAB2—Alzheimer's disease	1.2e-05	8.98e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NTRK2—Alzheimer's disease	1.2e-05	8.98e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—LPL—Alzheimer's disease	1.2e-05	8.97e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ACHE—Alzheimer's disease	1.2e-05	8.97e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GSK3A—Alzheimer's disease	1.19e-05	8.91e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—INPP5D—Alzheimer's disease	1.18e-05	8.86e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MAOB—Alzheimer's disease	1.17e-05	8.8e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PPARGC1A—Alzheimer's disease	1.17e-05	8.79e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APP—Alzheimer's disease	1.17e-05	8.75e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—HMOX1—Alzheimer's disease	1.17e-05	8.75e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MEF2C—Alzheimer's disease	1.16e-05	8.73e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PRKCG—Alzheimer's disease	1.16e-05	8.72e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—AGER—Alzheimer's disease	1.15e-05	8.66e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IAPP—Alzheimer's disease	1.15e-05	8.66e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PRKCG—Alzheimer's disease	1.14e-05	8.57e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NPS—Alzheimer's disease	1.14e-05	8.54e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PPP3CA—Alzheimer's disease	1.13e-05	8.5e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GAPDH—Alzheimer's disease	1.13e-05	8.47e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—AKT1—Alzheimer's disease	1.13e-05	8.44e-05	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—Alzheimer's disease	1.13e-05	8.44e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ENO1—Alzheimer's disease	1.12e-05	8.4e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.12e-05	8.38e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PTK2B—Alzheimer's disease	1.12e-05	8.37e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TGFB1—Alzheimer's disease	1.11e-05	8.36e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.11e-05	8.3e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—Alzheimer's disease	1.11e-05	8.3e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CCR5—Alzheimer's disease	1.1e-05	8.27e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PLCB1—Alzheimer's disease	1.1e-05	8.26e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP2D6—Alzheimer's disease	1.1e-05	8.24e-05	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—ESR1—Alzheimer's disease	1.1e-05	8.24e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—A2M—Alzheimer's disease	1.09e-05	8.18e-05	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.09e-05	8.18e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—MAPK8—Alzheimer's disease	1.09e-05	8.18e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CALM1—Alzheimer's disease	1.09e-05	8.17e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GAB2—Alzheimer's disease	1.09e-05	8.15e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SST—Alzheimer's disease	1.09e-05	8.15e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NTRK2—Alzheimer's disease	1.09e-05	8.15e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—NOS3—Alzheimer's disease	1.08e-05	8.12e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—MTHFR—Alzheimer's disease	1.08e-05	8.08e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GSK3A—Alzheimer's disease	1.08e-05	8.07e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—LPL—Alzheimer's disease	1.07e-05	8e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ENO1—Alzheimer's disease	1.06e-05	7.97e-05	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—NOTCH1—Alzheimer's disease	1.06e-05	7.96e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APP—Alzheimer's disease	1.06e-05	7.94e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PPP3CA—Alzheimer's disease	1.06e-05	7.93e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—BCHE—Alzheimer's disease	1.04e-05	7.81e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—Alzheimer's disease	1.04e-05	7.8e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NGFR—Alzheimer's disease	1.03e-05	7.71e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—AKT1—Alzheimer's disease	1.02e-05	7.66e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GAB2—Alzheimer's disease	1.01e-05	7.6e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CALM1—Alzheimer's disease	1.01e-05	7.55e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GSK3A—Alzheimer's disease	1e-05	7.53e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ADAM10—Alzheimer's disease	1e-05	7.53e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—APOE—Alzheimer's disease	1e-05	7.52e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PLCB1—Alzheimer's disease	9.99e-06	7.49e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CAV1—Alzheimer's disease	9.93e-06	7.45e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTGS2—Alzheimer's disease	9.9e-06	7.43e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—MAPK8—Alzheimer's disease	9.88e-06	7.41e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CALM1—Alzheimer's disease	9.88e-06	7.41e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APP—Alzheimer's disease	9.87e-06	7.41e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PLCB1—Alzheimer's disease	9.83e-06	7.37e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.73e-06	7.3e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.64e-06	7.23e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—MTHFR—Alzheimer's disease	9.61e-06	7.21e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ABCA1—Alzheimer's disease	9.53e-06	7.15e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ACHE—Alzheimer's disease	9.49e-06	7.12e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—S100B—Alzheimer's disease	9.49e-06	7.12e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—GSK3B—Alzheimer's disease	9.4e-06	7.05e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—INPP5D—Alzheimer's disease	9.38e-06	7.04e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS2—Alzheimer's disease	9.34e-06	7.01e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CREB1—Alzheimer's disease	9.33e-06	7e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NGFR—Alzheimer's disease	9.32e-06	6.99e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOTCH1—Alzheimer's disease	9.25e-06	6.94e-05	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	9.21e-06	6.91e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ADAM10—Alzheimer's disease	9.1e-06	6.83e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF2—Alzheimer's disease	9.04e-06	6.78e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CALM1—Alzheimer's disease	8.98e-06	6.73e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—APOE—Alzheimer's disease	8.94e-06	6.71e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PTGS1—Alzheimer's disease	8.89e-06	6.67e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ENO1—Alzheimer's disease	8.89e-06	6.67e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CAV1—Alzheimer's disease	8.86e-06	6.65e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF1R—Alzheimer's disease	8.74e-06	6.55e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	8.72e-06	6.54e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—GSK3B—Alzheimer's disease	8.68e-06	6.51e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CREB1—Alzheimer's disease	8.61e-06	6.46e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—S100B—Alzheimer's disease	8.61e-06	6.46e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—INS—Alzheimer's disease	8.57e-06	6.43e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—GSK3B—Alzheimer's disease	8.53e-06	6.4e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ADAM10—Alzheimer's disease	8.49e-06	6.37e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CREB1—Alzheimer's disease	8.46e-06	6.35e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—Alzheimer's disease	8.39e-06	6.3e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LPL—Alzheimer's disease	8.38e-06	6.28e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MEF2C—Alzheimer's disease	8.3e-06	6.23e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—BCHE—Alzheimer's disease	8.27e-06	6.2e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	8.21e-06	6.16e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF2—Alzheimer's disease	8.19e-06	6.15e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—HMOX1—Alzheimer's disease	8.17e-06	6.13e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PRKCG—Alzheimer's disease	8.14e-06	6.11e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NGF—Alzheimer's disease	7.93e-06	5.95e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF1R—Alzheimer's disease	7.92e-06	5.94e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—BCL2—Alzheimer's disease	7.83e-06	5.88e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PLCB1—Alzheimer's disease	7.8e-06	5.85e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—AKT1—Alzheimer's disease	7.74e-06	5.81e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR5—Alzheimer's disease	7.72e-06	5.79e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—INS—Alzheimer's disease	7.64e-06	5.73e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LPL—Alzheimer's disease	7.6e-06	5.7e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ABCA1—Alzheimer's disease	7.56e-06	5.67e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR2A—Alzheimer's disease	7.55e-06	5.67e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MEF2C—Alzheimer's disease	7.53e-06	5.65e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS3—Alzheimer's disease	7.51e-06	5.63e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—LPL—Alzheimer's disease	7.47e-06	5.61e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PRKCG—Alzheimer's disease	7.38e-06	5.54e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NGF—Alzheimer's disease	7.19e-06	5.4e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—BCL2—Alzheimer's disease	7.1e-06	5.33e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—LPL—Alzheimer's disease	7.09e-06	5.31e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CALM1—Alzheimer's disease	7.05e-06	5.29e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOE—Alzheimer's disease	7.02e-06	5.27e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LEP—Alzheimer's disease	7.02e-06	5.27e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR5—Alzheimer's disease	7e-06	5.25e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—Alzheimer's disease	6.96e-06	5.22e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CAV1—Alzheimer's disease	6.96e-06	5.22e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1B—Alzheimer's disease	6.92e-06	5.19e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PRKCG—Alzheimer's disease	6.89e-06	5.17e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—Alzheimer's disease	6.87e-06	5.15e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR2A—Alzheimer's disease	6.85e-06	5.14e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MTHFR—Alzheimer's disease	6.73e-06	5.05e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ESR1—Alzheimer's disease	6.7e-06	5.03e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—NOS3—Alzheimer's disease	6.7e-06	5.03e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—F2—Alzheimer's disease	6.62e-06	4.97e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CCR5—Alzheimer's disease	6.53e-06	4.9e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	6.52e-06	4.89e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—HMOX1—Alzheimer's disease	6.49e-06	4.87e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOTCH1—Alzheimer's disease	6.48e-06	4.86e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—AKT1—Alzheimer's disease	6.42e-06	4.82e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CALM1—Alzheimer's disease	6.39e-06	4.79e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MTHFR—Alzheimer's disease	6.38e-06	4.79e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOE—Alzheimer's disease	6.37e-06	4.78e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LEP—Alzheimer's disease	6.37e-06	4.78e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—MAPK8—Alzheimer's disease	6.35e-06	4.76e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—Alzheimer's disease	6.31e-06	4.73e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CAV1—Alzheimer's disease	6.31e-06	4.73e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CALM1—Alzheimer's disease	6.29e-06	4.72e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1B—Alzheimer's disease	6.28e-06	4.71e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOE—Alzheimer's disease	6.27e-06	4.7e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CAV1—Alzheimer's disease	6.21e-06	4.66e-05	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—AKT1—Alzheimer's disease	6.17e-06	4.63e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—Alzheimer's disease	6.13e-06	4.6e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GSK3B—Alzheimer's disease	6.08e-06	4.56e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ESR1—Alzheimer's disease	6.08e-06	4.56e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CREB1—Alzheimer's disease	6.03e-06	4.52e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—F2—Alzheimer's disease	6e-06	4.5e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—INS—Alzheimer's disease	6e-06	4.5e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CALM1—Alzheimer's disease	5.96e-06	4.47e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOE—Alzheimer's disease	5.94e-06	4.46e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—LPL—Alzheimer's disease	5.93e-06	4.45e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL2—Alzheimer's disease	5.9e-06	4.43e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CAV1—Alzheimer's disease	5.88e-06	4.41e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOTCH1—Alzheimer's disease	5.88e-06	4.41e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—AKT1—Alzheimer's disease	5.82e-06	4.37e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF1—Alzheimer's disease	5.8e-06	4.35e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MAPK8—Alzheimer's disease	5.76e-06	4.32e-05	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—AKT1—Alzheimer's disease	5.59e-06	4.19e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS2—Alzheimer's disease	5.53e-06	4.15e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GSK3B—Alzheimer's disease	5.51e-06	4.14e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOTCH1—Alzheimer's disease	5.48e-06	4.11e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CREB1—Alzheimer's disease	5.47e-06	4.1e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARG—Alzheimer's disease	5.46e-06	4.09e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—INS—Alzheimer's disease	5.44e-06	4.08e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—INS—Alzheimer's disease	5.35e-06	4.02e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL2—Alzheimer's disease	5.35e-06	4.01e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MTHFR—Alzheimer's disease	5.34e-06	4.01e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF1—Alzheimer's disease	5.26e-06	3.95e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOS3—Alzheimer's disease	5.26e-06	3.95e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GSK3B—Alzheimer's disease	5.14e-06	3.86e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CREB1—Alzheimer's disease	5.1e-06	3.83e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—INS—Alzheimer's disease	5.07e-06	3.81e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CALM1—Alzheimer's disease	4.99e-06	3.74e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—AKT1—Alzheimer's disease	4.98e-06	3.73e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOE—Alzheimer's disease	4.97e-06	3.73e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—Alzheimer's disease	4.97e-06	3.73e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CAV1—Alzheimer's disease	4.93e-06	3.7e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOS3—Alzheimer's disease	4.77e-06	3.58e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NOS3—Alzheimer's disease	4.69e-06	3.52e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CASP3—Alzheimer's disease	4.47e-06	3.35e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS3—Alzheimer's disease	4.45e-06	3.34e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARG—Alzheimer's disease	4.33e-06	3.25e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—Alzheimer's disease	4.29e-06	3.22e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—INS—Alzheimer's disease	4.25e-06	3.19e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAPK8—Alzheimer's disease	4.1e-06	3.08e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—Alzheimer's disease	4.05e-06	3.04e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CASP3—Alzheimer's disease	4.05e-06	3.04e-05	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—AKT1—Alzheimer's disease	3.96e-06	2.97e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—VEGFA—Alzheimer's disease	3.79e-06	2.84e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—Alzheimer's disease	3.74e-06	2.81e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—AKT1—Alzheimer's disease	3.74e-06	2.81e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NOS3—Alzheimer's disease	3.73e-06	2.8e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAPK8—Alzheimer's disease	3.72e-06	2.79e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—Alzheimer's disease	3.68e-06	2.76e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—Alzheimer's disease	3.48e-06	2.61e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—AKT1—Alzheimer's disease	3.45e-06	2.59e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—VEGFA—Alzheimer's disease	3.44e-06	2.58e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—AKT1—Alzheimer's disease	3.39e-06	2.54e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—Alzheimer's disease	3.15e-06	2.37e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—AKT1—Alzheimer's disease	3.08e-06	2.31e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—Alzheimer's disease	2.94e-06	2.21e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—Alzheimer's disease	2.86e-06	2.15e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—Alzheimer's disease	2.62e-06	1.97e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—Alzheimer's disease	2.6e-06	1.95e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AKT1—Alzheimer's disease	2.42e-06	1.81e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—Alzheimer's disease	2.38e-06	1.78e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—Alzheimer's disease	2.22e-06	1.66e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AKT1—Alzheimer's disease	2.19e-06	1.64e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AKT1—Alzheimer's disease	2.16e-06	1.62e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—AKT1—Alzheimer's disease	2.05e-06	1.53e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AKT1—Alzheimer's disease	1.71e-06	1.28e-05	CbGpPWpGaD
